chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: HEPA
Symptoms: No adverse event, Underdose
Clinical narrative: Havrix 720EL U/0.5ml which is indicated for 9 - 18yo was administered  the patient was 52yo and should have received Havrix 1440EL U/1ml.  Upon following up to complete the Havrix series after 6 months and error was discovered.  Patient came to a follow up appt this morning 0930 the issue was explained, and a plan was agreed upon to re-vaccinate in 6 months to complete the Havrix series 2 of 2 with the 1440EL U/1ml - so she will be properly protected against Hepatitis A if exposed.  The patient was very understanding and agreed to follow up in 6 months to complete Havrix Series. Patient did not have an adverse event from this error but was not properly immunized at the initiation of the Havrix series.  Which we will follow through to correct.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness, Dry eye, Eye pain, Magnetic resonance imaging normal
Clinical narrative: Swelling of left side of face and neck especially lymph node area.  Pain next to left eye.  Persisting tinnitus in both ears whereas none existed before.  Vision changes.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Swelling face, Tinnitus, Visual impairment
Clinical narrative: Swelling of left side of face and neck especially lymph node area.  Pain next to left eye.  Persisting tinnitus in both ears whereas none existed before.  Vision changes.
Age: 79.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Fatigue, Headache, Myalgia
Clinical narrative: Began feeling very tired, bad headache, joint/muscle pain lasting approx. 30 hours begining the following morning.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEPA, PNC20, RSV, RV5
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient age at time of vaccination does not meet minimum age for Hep A vaccine. Per office staff, provider notified, mother notified, and mother denied any adverse reaction of patient. Mom advised the vaccination did not meet minimum age requirement for the Hep A vaccine and would need to be revaccinated when age and time appropriate. Mother verbalized understanding to office staff.
Age: 59.0
Sex: F
Vaccine: PNC20
Symptoms: Blood test normal, Chest X-ray normal, Computerised tomogram abdomen normal, Computerised tomogram head normal, Dysphagia
Clinical narrative: Burning pain in the mastoid bone (both ears.) Lymph nodes in throat popped out. trouble swallowing.  Severe nausea. weight loss between six and seven pounds. Nausea and ear pain ongoing.
Age: 59.0
Sex: F
Vaccine: PNC20
Symptoms: Ear discomfort, Ear pain, Lymphadenopathy, Nausea, Weight decreased
Clinical narrative: Burning pain in the mastoid bone (both ears.) Lymph nodes in throat popped out. trouble swallowing.  Severe nausea. weight loss between six and seven pounds. Nausea and ear pain ongoing.
Age: 19.0
Sex: M
Vaccine: HEP, MMR, UNK
Symptoms: Dizziness
Clinical narrative: Patient reports to staff between vaccinations and TST that he needed a moment and was feeling lightheaded, after TST administration, patient began to felt dizzy and asked staff if he could lay down. staff assisted patient to ambulate to the treatment room, laid patient back and took vital signs at 0846. initial vitals of BP 105/66, HR 50. Staff took repeat vitals q5min with vitals at 0851 of 112/49 57HR, time 0856 of 116/56 HR 62. patient began to feel better, and staff took orthostatic BP at 0902 wit BP 129/71 HR 64 while sitting, BP 116/56 HR 63 while standing. Patient felt better and requested to leave. Patient notified to establish follow up appointment with PCM.
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: Paraesthesia, Urticaria
Clinical narrative: Approximately 8:45 PM, I started getting a prickly feeling on my back and head, soon my back was completely covered in hives, a few on my head too. My vaccine was given at approximately 5:15 PM. It lasted about 2 hours after taking 50mg of Benadryl. Today 03/12/2025 the hives came back and I returned to the clinic at approximately 10:30 AM.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cognitive disorder, Electrocardiogram, Fatigue, Hypothyroidism, Laboratory test
Clinical narrative: MAILAISE, POST-EXERTIONAL FATIGUE, DIFFICULTIES WITH MEMORY AND DECISION MAKING, DEVELOPED HYPOTHYROIDISM.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Memory impairment
Clinical narrative: MAILAISE, POST-EXERTIONAL FATIGUE, DIFFICULTIES WITH MEMORY AND DECISION MAKING, DEVELOPED HYPOTHYROIDISM.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Bradycardia, Pallor, Presyncope
Clinical narrative: Vasovagal reaction after HPV given left prox deltoid. BP 98/68 pulse 57.  - laid down, prone position. re-eval: alert, aware to person, place, time. Pale. CV: bradycardia. RR: 18. Given: given 1-2 oz of protein milk shake (patient was fasting)  - 10:25AM: BP improved, Pulse improved. Re-eval: sitting up, alert, talkative, jumped off bed and walking without ataxia, normal balance.  - Report adverse reaction documentation warranted.
Age: 48.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Pt. received 2 doses of flu vaccine for this season by mistake, the first dose was on 9-25-2023 and the second dose was on 02-22-2024
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU4, IPV, MMRV
Symptoms: Extra dose administered
Clinical narrative: Did not intend to administer Kinrix.  Saw the descriptor of Diptheris, Tetnus and Pertussis , and did not intend to but pulled from that box 1 dose to admin. Did not realize it had the IPV component too.  Single vaccine IPV admin as scheduled. Influenza and MMRV administered in same visit.
Age: 49.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered
Clinical narrative: Pt received an extra dose by mistake. first dose was on 2/7/2023 and additional dose on 01/26/2024
Age: 79.0
Sex: F
Vaccine: RSV
Symptoms: Erythema, Headache, Peripheral swelling, Skin warm, Vomiting
Clinical narrative: The day after her vaccine,  her arm was swollen, red, and hot.  This persisted and by day 5 she was experiencing headaches and vomiting. The emergency squad was contacted and she was taken to the ER and treated and released.  Today is day 7 and her arm is still a bit swollen and red.   Patient reports having a similar reaction when she had her pneumonia vaccine.
Age: 58.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: This adult 57 year old patient at the time was given the Hep B dosing for peds/adolescents.
Age: 32.0
Sex: M
Vaccine: HPV9
Symptoms: Injection site bruising, Injection site nodule
Clinical narrative: Bruising after shot, after resolution of same noted a persistent subcutaneous nodule about 1 cm across at injection site; no pain or limitation of use of shoulder
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Patient complained of pain in both legs, headache, fever of 101.1 , fatigue a couple hours after receiving the first dose of vaccine. She continued to feel fatigued, headache and pain in legs the next day
Age: 13.0
Sex: M
Vaccine: HEPA
Symptoms: Dizziness, Feeling hot
Clinical narrative: child became dizzy and hot after receiving vaccines
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiocardiogram, Blood test abnormal, Chest discomfort, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: March 23/2021 I received my first COVID vaccine from Pharmacy, I had the normal side effects as stated in the paperwork provided to me from the pharmacy, usual soreness in the injection site no other symptoms.  I went about my daily routine of exercise on 3/30/21.  I began to sweat profusely, my chest began to fill tight and I couldn't breath.  An employee at the facility noticed me having trouble breathing and went to get anther employee to assist.  I proceeded to leave the facility and called my wife letting her know I wasn't feeling well, we continued to speak on the phone as I drove home.  My wife called EMS and I was take to the Hospital where I was diagnosed as having a heart attack.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Injection site pain, Malaise, Myocardial infarction, Percutaneous coronary intervention
Clinical narrative: March 23/2021 I received my first COVID vaccine from Pharmacy, I had the normal side effects as stated in the paperwork provided to me from the pharmacy, usual soreness in the injection site no other symptoms.  I went about my daily routine of exercise on 3/30/21.  I began to sweat profusely, my chest began to fill tight and I couldn't breath.  An employee at the facility noticed me having trouble breathing and went to get anther employee to assist.  I proceeded to leave the facility and called my wife letting her know I wasn't feeling well, we continued to speak on the phone as I drove home.  My wife called EMS and I was take to the Hospital where I was diagnosed as having a heart attack.
Sex: M
Vaccine: DTPPVHBHPB
Symptoms: Body temperature increased, Emotional distress, Injection site erythema, Screaming
Clinical narrative: his entire thigh turned bright red extending past his knee and he was inconsolably screaming for hours. Axillary temp went up to 102.6
Age: 4.0
Sex: M
Vaccine: PPV
Symptoms: Decreased appetite, Fatigue, Gait disturbance
Clinical narrative: My son was limping for a week and was very fatigue, and loss of appetite.
Age: 73.0
Sex: M
Vaccine: RSV
Symptoms: Arthralgia, Blood test normal, Myalgia
Clinical narrative: Aching muscles, joint soreness in shoulders, biceps, wrists, and hands, Bilateral and persistent. Continuing thru current date.
Age: 6.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: N/a
Age: 77.0
Sex: F
Vaccine: ANTH, FLU4
Symptoms: Acute motor axonal neuropathy, Anti-ganglioside antibody, CSF protein increased, CSF white blood cell count negative, Guillain-Barre syndrome
Clinical narrative: quick progression of bilateral arm and leg weakness leading to flaccid quadriplegia ( 1day). working diagnosis is Gulian bare syndrome ( acute motor axonal neuropathy) variant.
Age: 77.0
Sex: F
Vaccine: ANTH, FLU4
Symptoms: Magnetic resonance imaging spinal normal, Muscular weakness, Quadriplegia, West Nile virus test negative
Clinical narrative: quick progression of bilateral arm and leg weakness leading to flaccid quadriplegia ( 1day). working diagnosis is Gulian bare syndrome ( acute motor axonal neuropathy) variant.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Hypoaesthesia, Injection site hypoaesthesia, Injection site nodule, Injection site warmth
Clinical narrative: Patient has a small knot at the injection site about the size of a dime. Is palpable and warm to touch. Patient also complains of numbness from the inside of her arm to her finger tips
Age: 31.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: 12 days after injection I started getting hives all over my body. I contacted my PCP because I thought it was a common rash. They suggested I take an Zyrtec. My hives persisted and I reached out again. I was seen by a different doctor and his supervisor. They said it was hives and bumped me up to 40 mg of Zyrtec. The hives persisted easily though the Zyrtec and I reached out again. I was placed on a mix of xyzal, Pepcid, and Benadryl daily by an allergist. The hives still persisted and I started xolair injections monthly. The clair helped, but I was misquoted $45 for the injections when they were actually $800. I had to stop treatment and the hives persisted immediately.  It has been a year since they started.
Age: 65.0
Sex: F
Vaccine: RSV
Symptoms: Injection site bruising, Injection site discolouration, Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Redness. bruising. skin discoloration, warm to touch, itchness, at the injection site.
Age: 18.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Amenorrhoea, Exposure during pregnancy, Pregnancy test positive
Clinical narrative: This client was vaccinated with hep a, mmr, and varicella on 02/24/2024. On  03/07/2024 she returned to clinic and reported she has missed her period. A pregnancy test was ran and it was positive. Client reported her LMP as  01/23/2024. Gestation was about 4 weeks at the time of vaccine administration. The client has decided to continue with the pregnancy. The EDD 10/29/2024
Age: 1.17
Sex: F
Vaccine: MMRV
Symptoms: Pyrexia, Rash vesicular
Clinical narrative: RASH APPEARING LIKE CHICKENPOX PER PROVIDER.  FEVER.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dental prosthesis user, Diverticulitis, Neutrophil percentage decreased, Pyrexia, Rectal abscess
Clinical narrative: I have a question regarding my husband and future covid vaccines.    I am a physician myself, a psychiatrist,  I am very pro vaccine, still I have a question regarding a possible adverse effect.    My husband, an overall healthy 69 year old, fit, received his 7th covid shot on October 3rd. 2023 (No flu vaccine on that day). He received Moderna, most of his prior ones had been Pfizer. Around the same time he had a confirmed deer tic bite while hiking in the area, that was discovered by his dermatologist, still attached, a couple of days later.  He was prescribed a one day large dose of Doxycycline, 8 tabs in 1 day, in addition to Amoxicillin he was taking for a tooth implant.    His WBC were in normal range, 6.2, in July 2023, done for a physical exam. On October 16 he had bloodwork done for a prep op, for planned hip replacement, and it was found that his WBC were low at 1.9, mostly at the expense of neutrophils that were low at 12% Repeated on October 18 for a planned trip, it had gone up slightly to 2,3 and we decided to travel for a family visit.    On arrival he had fever, was seen by a PCP there and determined his WBC were 0.7 on October 20, he had a, likely opportunistic, rectal abscess and diverticulitis.  He was hospitalized, treated with Neupogen for stimulation of bone marrow and responded very well. WBC normalized in a couple of days.   He was discharged after 5 days with a basically normal count, no fever and otherwise healthy.    WBCs have remained normal since then.   Hematologists and other doctors he has seen remain split regarding possible cause of his drop in WBCs, neutrophils mostly. It does not seem he acquired Lyme disease.  Some doctors believe it was caused by doxycycline, though I do not see any reports about it, others believe it was the vaccine, which I know can cause transient benign low WBCs.  Others blame the tic but it would have been to soon to cause a drop like that 12 days after the bite and with treatment.    Any thoughts? Should he avoid covid vaccine in the future or switch to Novavax? Or Pfizer mRNA? Are there any similar reports with mRNA vaccines or with doxycycline?   Thank you for your help, if needed I have all his labs and medical history. I attach a list of his meds but none was a recent change and he has continued them. If helpful, I have all his lab reports.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: White blood cell count decreased
Clinical narrative: I have a question regarding my husband and future covid vaccines.    I am a physician myself, a psychiatrist,  I am very pro vaccine, still I have a question regarding a possible adverse effect.    My husband, an overall healthy 69 year old, fit, received his 7th covid shot on October 3rd. 2023 (No flu vaccine on that day). He received Moderna, most of his prior ones had been Pfizer. Around the same time he had a confirmed deer tic bite while hiking in the area, that was discovered by his dermatologist, still attached, a couple of days later.  He was prescribed a one day large dose of Doxycycline, 8 tabs in 1 day, in addition to Amoxicillin he was taking for a tooth implant.    His WBC were in normal range, 6.2, in July 2023, done for a physical exam. On October 16 he had bloodwork done for a prep op, for planned hip replacement, and it was found that his WBC were low at 1.9, mostly at the expense of neutrophils that were low at 12% Repeated on October 18 for a planned trip, it had gone up slightly to 2,3 and we decided to travel for a family visit.    On arrival he had fever, was seen by a PCP there and determined his WBC were 0.7 on October 20, he had a, likely opportunistic, rectal abscess and diverticulitis.  He was hospitalized, treated with Neupogen for stimulation of bone marrow and responded very well. WBC normalized in a couple of days.   He was discharged after 5 days with a basically normal count, no fever and otherwise healthy.    WBCs have remained normal since then.   Hematologists and other doctors he has seen remain split regarding possible cause of his drop in WBCs, neutrophils mostly. It does not seem he acquired Lyme disease.  Some doctors believe it was caused by doxycycline, though I do not see any reports about it, others believe it was the vaccine, which I know can cause transient benign low WBCs.  Others blame the tic but it would have been to soon to cause a drop like that 12 days after the bite and with treatment.    Any thoughts? Should he avoid covid vaccine in the future or switch to Novavax? Or Pfizer mRNA? Are there any similar reports with mRNA vaccines or with doxycycline?   Thank you for your help, if needed I have all his labs and medical history. I attach a list of his meds but none was a recent change and he has continued them. If helpful, I have all his lab reports.
Age: 94.0
Sex: M
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Emphysema
Clinical narrative: I82.4Z1 ACUTE DVT OF RIGHT CALF, UNSPECIFIED VEIN 10/11/2023 EMPHYSEMA
Age: 69.0
Sex: F
Vaccine: RSV
Symptoms: Rash
Clinical narrative: PATIENT STATES THAT SEVERAL HOURS AFTER THE VACCINE WAS GIVEN, SHE EXPERIENCED A FULL BODY RASH. SHE WAS ADMITTED TO THE ER AND WAS INITIALLY TREATED WITH TWO DOSES OF EPINEPHRINE TO WHICH SHE DID NOT RESPOND AND FURTHER TREATMENT WAS NEEDED.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The medical assistant administered the entire vial ( 3 doses of 0.3 ml) of the covid vaccine to the patient on 3/12/2024
Age: 17.0
Sex: F
Vaccine: HPV9
Symptoms: Immediate post-injection reaction, Loss of consciousness, Syncope
Clinical narrative: Patient experienced syncopal episode immediately after vaccine administration. She was caught and supported by this RN and the patient's mother and prevented from falling off the table. Patient was unconscious for approximately 10 seconds. She was given water and a granola bar upon awakening. Her blood pressure was 100/76. She was feeling better after being monitored for about 20 minutes and left accompanied by her mother.
Age: 7.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: MA gave the Flumist to the patient at their visit on 12/20/2023. The immunization expired on 12/19/2023. Provider was informed of medical assistant giving the vaccination after the date of expiration. Provider informed to contact the patient to discuss the Flumist being given to patient after the date of expiration and follow up recommendations.
Age: 71.0
Sex: F
Vaccine: DF
Symptoms: Diarrhoea
Clinical narrative: Diarrhea
Age: 1.08
Sex: U
Vaccine: HEPA
Symptoms: Expired product administered, No adverse event
Clinical narrative: The patient had not experienced any adverse issues or side effects from the administration of the expired dose; VAQTA (expiration: 12/13/2023) had inadvertently been administered to a patient on 12/28/2023; This spontaneous report was received from a medical assistant and refers to a 13-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 28-DEC-2023, the patient was inadvertently vaccinated with an expired dose (expired product administered) of hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, lot # reported and confirmed as: W017343, expiration date: 13-DEC-2023 (dose number, exact dose, site and route of administration were not provided) for prophylaxis, by a healthcare professional. The dose of hepatitis a vaccine, inactivated (VAQTA) had not been exposed to any temperature excursions and was supported on the post-expiry memo. The patient had not experienced any adverse issues or side effects from the administration of the expired dose. There was no additional adverse event reported.
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE/; The HCP called to report that the patient was inadvertently administered VAQTA that was involved in a not supported below range TE. No symptomatic adverse events were reported. No additional information provided. No additional AE/PQC.    ?    Names; This spontaneous report was received from a nurse referring to a patient with unknown age and gender. The patient's pertinent medical history and drug reactions/ allergies and concomitant medication were not reported.   On 29-FEB-2024, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, lot #X010374, expiration date: 13-NOV-2024, administered for prophylaxis (strength, dose, anatomical location, and route of administration were not provided) following a temperature excursion (the temperature was minus 2.2 degree Celsius, time frame was 1 hour 3 minutes 0 seconds) (product storage error). No symptomatic adverse events were reported. No additional adverse event (AE) was reported (no adverse event).
Age: 26.0
Sex: M
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No symptomatic adverse events were reported; Nurse calling to report administration of PROQUAD to a 26 year old male.; This spontaneous report was received from a nurse and refers to a 26-year-old male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 05-MAR-2024, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) injection, 0.5 milliliter, once, lot #X011437, expiration date: 18-JUL-2024, administered for prophylaxis (strength, and route of administration were not provided) (Product administered to patient of inappropriate age). No symptomatic adverse events were reported.
Sex: U
Vaccine: PPV
Symptoms: Drug specific antibody absent, Immunoglobulins normal, Therapy non-responder
Clinical narrative: 1 patient was diagnosed with specific antibody deficiency (SAD); patient was considered to have SAD based on normal quantitative immunoglobulin (Ig) levels and a nonprotective response to the PPSV23; 1 patient was diagnosed with specific antibody deficiency (SAD); patient was considered to have SAD based on normal quantitative immunoglobulin (Ig) levels and a nonprotective response to the PPSV23; This literature marketed report has been received from the authors of a published literature article and refers to a child.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date, the patient started therapy with pneumococcal 23v polysaccharide vaccine (manufacturer unknown) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On an unknown date, the patient was diagnosed with specific antibody deficiency (SAD). The patient was considered to have SAD based on normal quantitative immunoglobulin (Ig) levels and a nonprotective response to the pneumococcal 23v polysaccharide vaccine (manufacturer unknown) (therapy non-responder).  The outcome of events was not reported. The author considered SAD and nonprotective response to be related to pneumococcal 23v polysaccharide vaccine (manufacturer unknown).  Upon internal review, the event of SAD was determined to be medically significant.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure/have had two mild cases of shingles; shingles/ two mild cases of shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure/have had two mild cases of shingles) (serious criteria GSK medically significant) and shingles (Verbatim: shingles/ two mild cases of shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 29-FEB-2024 This case was reported by a patient via interactive digital media. The patient got both shingle shots at the local pharmacy about 2 months apart and have had two mild cases of shingles but had no reactions to the shots at all. This case was considered as suspected vaccination failure since the details regarding the  time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Suspected vaccination failure; still got shingles; still have pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (had the first shot that came out).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: still got shingles) and pain (Verbatim: still have pain). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 04-MAR-2024 This case was reported by a patient via interactive digital media. The patient stated that he/she had the first shot that came out and then got the last two they came out with but still got shingles. The patient still had them at the time of reporting, not as bad as they were to start with but it had been almost 1 and 1/2 and still had pain it seemed worse in the evening when the patient got tired not much could be done for them. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Something tells me it is a repercussion of toxic vaccines, I never knew anyone who got it that was not vaccinated/ Suspected vaccination failure; I never knew anyone who got it that was not vaccinated; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Something tells me it is a repercussion of toxic vaccines, I never knew anyone who got it that was not vaccinated/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I never knew anyone who got it that was not vaccinated). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 05-MAR-2024 This case was reported via interactive digital media. It was told to the reporter that it was a repercussion of toxic vaccines. The reporter never knew anyone who got it that was not vaccinated. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Eye pain, Herpes zoster, Ophthalmic herpes zoster, Retinal scar, Vaccination failure
Clinical narrative: I still get them / suspected vaccination failure; I still get them. around my eye, in my eyes; I still get them. around myeye, in my eyes, down my face; I have a scar on the retina; Pain in my eyes; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I still get them / suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: I still get them. around my eye, in my eyes) (serious criteria GSK medically significant), shingles (Verbatim: I still get them. around myeye, in my eyes, down my face), retinal scar (Verbatim: I have a scar on the retina) and eye pain (Verbatim: Pain in my eyes). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster, shingles and retinal scar were not reported and the outcome of the eye pain was not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, shingles, retinal scar and eye pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster, shingles, retinal scar and eye pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 05-Mar-2024 This case was reported by the patient via interactive digital media. The patient had the shingles vaccine and still got them around eyes, in eyes and down face. The patient stated that he/she had a scar on the retina because of them. The patient further stated the last bout was a year and half ago and he/she still got the pain in his/her eyes. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: shingles for the second time / Suspected vaccination failure; I've got shingles for the second time; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: shingles for the second time / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I've got shingles for the second time). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolving.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 05-Mar-2024 This case was reported by the patient via interactive digital media. The patient stated that he/she had got the shingles for the second time. The patient stated that he/she was glad that had two shots of vaccine. The patient further stated that pain medications caused other problems but gradually getting better. This case was considered as suspected vaccination failure as details time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Ophthalmic herpes zoster, Pain, Stress, Vaccination failure
Clinical narrative: Stress; Extremely painful; Patient still got them after vaccination/Susptected vaccination failure; Shingles under the left eyelid about half an inch down; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (2 times).   On an unknown date, the patient received Shingles vaccine. In JUL-2023, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Patient still got them after vaccination/Susptected vaccination failure) (serious criteria GSK medically significant) and ophthalmic herpes zoster (Verbatim: Shingles under the left eyelid about half an inch down) (serious criteria GSK medically significant). On an unknown date, the patient experienced stress (Verbatim: Stress) and pain (Verbatim: Extremely painful). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster, stress and pain were not reported.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, stress and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster, stress and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 05-MAR-2024 This case was reported by a patient via interactive digital media. The patient stated that he/she had them 3 times. After 2 times the patient finally got the vaccine. But the patient still got them last July after he/she lost the Husky. Went to quick care and doctor said it was from the stress from that. They were right under the left eyelid about half an inch down. So extremely painful.  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome
Clinical narrative: Gillian Barre; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: Gillian Barre) (serious criteria hospitalization and GSK medically significant). The outcome of the guillain barre syndrome was not reported.   The reporter considered the guillain barre syndrome to be related to Shingles vaccine.     The company considered the guillain barre syndrome to be related to Shingles vaccine.   Additional Information: GSK received date: 08-Mar-2024 This case was reported by a patient via interactive digital media. Patient got Gillian Barre from the shingles shot, too. Patient stated, he/she was just about died. Patient was in the hospital 2 weeks and rehab for patient was for 2 weeks. Patient will not be taking the second one. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Ophthalmic herpes zoster, Pruritus, Vaccination failure
Clinical narrative: had shingles in my left eye after I had both vaccinations/Suspected vaccination failure; Shingles in my left eye; itchiness; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shingles in my left eye after I had both vaccinations/Suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: Shingles in my left eye) (serious criteria GSK medically significant) and pruritus (Verbatim: itchiness). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster was resolving and the outcome of the pruritus was not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and pruritus to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster and pruritus to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK received date: 08-Mar-2024 This case was reported by a patient via interactive digital media. The patient reported that he or she had shingles in his or her left eye after received both vaccinations.  The patient had them since before Christmas. The patient thought that was the worst place you could have them.  Patient could not imagine how much worse it would be if he or she had not taken the vaccine.  The patient thought they were getting better and was in the itchiness now, so might be they were starting to heal. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: sore arm). The outcome of the pain in arm was resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-Mar-2024 This case was reported by a patient via interactive digital media. Patient had both Shingles vaccine and only got a sore arm for 2 to 3 days. Patient guessed it affects everybody differently.
Sex: U
Vaccine: RSV
Symptoms: Feeling hot
Clinical narrative: 100 degree fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, 1 day after receiving Arexvy, the patient experienced fever (Verbatim: 100 degree fever). The outcome of the fever was not reported.   It was unknown if the reporter considered the fever to be related to Arexvy.     It was unknown if the company considered the fever to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-MAR-2024 This case was reported by a patient via (Open field AE monitoring) interactive digital media. The patient stated that ran a 100 degree fever the day after vaccination.
Sex: U
Vaccine: RSV
Symptoms: Feeling abnormal
Clinical narrative: not feeling good; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling abnormal in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced feeling abnormal (Verbatim: not feeling good). The outcome of the feeling abnormal was not reported.   It was unknown if the reporter considered the feeling abnormal to be related to Arexvy.     It was unknown if the company considered the feeling abnormal to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-MAR-2024 The case was received from the patient via interactive digital media. The patient received dose of Arexvy vaccine and had all of the side effects, not a good feeling.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine (unknown arm). On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: sore arm). The outcome of the pain in arm was resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 02-MAR-2024 This case was reported by the patient via interactive digital media. The reporter reported that got 2 shots only had a sore arm for a couple days the reporter's mom got Shingles and reporter's aunt back then they didn't have shots, the reporter's cousin got Shingles on the inside and a friend got them on the inside please get you're shots The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (one of the most painful things patient ever experienced) and pain.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Painful). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 02-MAR-2024 This case was reported by a patient via interactive digital media. The patient stated that, the vaccine was 100 times less painful.
Sex: U
Vaccine: RSV
Symptoms: Cough, Nasopharyngitis
Clinical narrative: cough; cold symptoms; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cough in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, 1 day after receiving Arexvy, the patient experienced cough (Verbatim: cough) and cold symptoms (Verbatim: cold symptoms). The outcome of the cough and cold symptoms were not reported.   It was unknown if the reporter considered the cough and cold symptoms to be related to Arexvy.     It was unknown if the company considered the cough and cold symptoms to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-MAR-2024 This case was reported by a patient via (Open field AE monitoring) interactive digital media. The patient stated that, he/she came down with a cough and cold symptoms after the injection the next day and he/she asked why.
Sex: U
Vaccine: RSV
Symptoms: Fatigue
Clinical narrative: very tired; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced tiredness (Verbatim: very tired). The outcome of the tiredness was not reported.   It was unknown if the reporter considered the tiredness to be related to Arexvy.     It was unknown if the company considered the tiredness to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-Mar-2024 This case was reported by a patient via (Open field AE monitoring) interactive digital media. The patient had been very tired, and he/she was glad to know it was a side effect.  The patient wanted to know how long does it usually last.
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Achiness for several hours; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: Fever), chills (Verbatim: Chills) and pain (Verbatim: Achiness for several hours). The outcome of the fever, chills and pain were resolved.   It was unknown if the reporter considered the fever, chills and pain to be related to Shingles vaccine.     It was unknown if the company considered the fever, chills and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 02-MAR-2024 This case was reported by a patient via interactive digital media. The reporter stated, after his/her first shot, he/she had fever, chills, achiness for several hours.  After the second one two months later he/she had no issues.
Sex: U
Vaccine: RSV
Symptoms: Arthralgia, Myalgia
Clinical narrative: Joint pain; muscle pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced joint pain (Verbatim: Joint pain) and muscle pain (Verbatim: muscle pain). The outcome of the joint pain and muscle pain were not resolved.   It was unknown if the reporter considered the joint pain and muscle pain to be related to Arexvy.     It was unknown if the company considered the joint pain and muscle pain to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-MAR-2024 This case was reported by a patient via (Open field AE monitoring) interactive digital media. The patient stated that he/she till had terrible joint and muscle pain after 10 days.